Full Text View
Tabular View
No Study Results Posted
Related Studies
Hydroxyurea in Treating Patients With Recurrent and/or Unresectable Meningioma
This study is ongoing, but not recruiting participants.
Study NCT00006119   Information provided by National Cancer Institute (NCI)
First Received: August 3, 2000   Last Updated: July 23, 2008   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Additional conditions recognized in this trial
Central Nervous System Neoplasms
Meningioma
Nervous System Neoplasms
More general conditions related to this trial
Meningeal Neoplasms
Neoplasms
Neoplasms by Histologic Type
Neoplasms by Site
Neoplasms, Nerve Tissue
Neoplasms, Vascular Tissue
Nervous System Diseases
Interventions listed in this trial
hydroxyurea
More general drug interventions related to this trial
Antineoplastic Agents
Antisickling Agents
Enzyme Inhibitors
Hematologic Agents
Molecular Mechanisms of Pharmacological Action
Nucleic Acid Synthesis Inhibitors
Pharmacologic Actions
Therapeutic Uses
Sponsors listed in this trial
Federation Nationale des Centres de Lutte Contre le Cancer


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services